抗菌药物管理评价指标和评估方法研究进展

吴嘉昱, 杨阳, 左玮, 于佳鑫, 乔露瑶, 张波

中国药学杂志 ›› 2023, Vol. 58 ›› Issue (15) : 1349-1354.

PDF(992 KB)
中国药学杂志
PDF(992 KB)
中国药学杂志 ›› 2023, Vol. 58 ›› Issue (15) : 1349-1354. DOI: 10.11669/cpj.2023.15.002
综述

抗菌药物管理评价指标和评估方法研究进展

  • 吴嘉昱1, 杨阳1, 左玮1, 于佳鑫1, 乔露瑶2, 张波1*
作者信息 +

Research Progress on Evaluation Outcomes and Study Designs of Antimicrobial Stewardship Programs

  • WU Jia-yu1, YANG Yang1, ZUO Wei1, YU Jia-xin1, QIAO Lu-yao2, ZHANG Bo1*
Author information +
文章历史 +

摘要

抗菌药物管理项目(antimicrobial stewardship program,ASP)是一项由多学科医疗团队干预抗菌药物使用以促进抗菌药物合理使用、保障医疗质量和医疗安全的干预项目。随着抗菌药物管理的开展,确定合适的评价方法和评价指标作为证明ASP干预措施有效性至关重要。笔者通过查阅梳理国内外抗菌药物管理政策效果评价领域的相关文献,对不同评价指标与评价方法等方面进行了综述。总结了ASP主要的4个指标:临床结局指标、微生物指标、过程指标、经济学效益,以及包括随机对照试验、随机整群对照试验、中断时间序列分析、Meta分析等ASP的评价方法,为进一步完善抗菌药物管理政策提供参考,也为后续相关研究提供方向和依据。

Abstract

The Antimicrobial Stewardship Program (ASP) is a work in which multidisciplinary medical teams intervene in the use of antibacterial drugs to promote rational clinical drug use and ensure medical quality and safety. With the development of antimicrobial management, it is very important to determine appropriate evaluation methods and outcomes to prove the effectiveness of ASP interventions. This paper reviews different evaluation indicators and methods by reviewing the relevant literature in the field of evaluation of the effectiveness of antimicrobial drug management policies at home and abroad. This paper summarizes the four main outcomes of ASP: clinical outcomes, microbial outcomes, process outcomes, economic outcomes, and methodology, including randomized controlled trials, randomized cluster controlled trial, interruption time series analysis and meta analysis. This paper could provide reference for further improving the management policy of ASP, and also provide direction and basis for subsequent related research.

关键词

抗菌药物管理项目 / 干预 / 效果 / 评价指标 / 评估方法

Key words

ASP / intervention / effect / outcome / methodology

引用本文

EndNote

Ris (Procite)

Bibtex

导出引用
吴嘉昱, 杨阳, 左玮, 于佳鑫, 乔露瑶, 张波. 抗菌药物管理评价指标和评估方法研究进展[J]. 中国药学杂志, 2023, 58(15): 1349-1354 https://doi.org/10.11669/cpj.2023.15.002
WU Jia-yu, YANG Yang, ZUO Wei, YU Jia-xin, QIAO Lu-yao, ZHANG Bo. Research Progress on Evaluation Outcomes and Study Designs of Antimicrobial Stewardship Programs[J]. Chinese Pharmaceutical Journal, 2023, 58(15): 1349-1354 https://doi.org/10.11669/cpj.2023.15.002
中图分类号： R95   

参考文献

[1] BLUMENTHAL K G, PETER J G, TRUBIANO J A, et al. Antibiotic allergy [J]. Lancet, 2019, 393(10167): 183-198.
[2] Centers for Disease Control and Prevention. Core elements of antibiotic stewardship programs [EB/OL]. Atlanta, GA: US Department of Health and Human Services, CDC, 2021 [2022-11-10]. https://www.cdc.gov/antibiotic-use/core-elements/hospital.html.
[3] National Health and Family Planning Commission. Measures for the administration of clinical application of antibacterial drugs [EB/OL]. 2022 [2022-11-10]. http://www.nhc.gov.cn/wjw/c100022/202201/8fcae32c3f1f467eb795ee816e2387d6.shtml.
[4] MEI X B, ZHONG W Y, ZHANG X J, et al. The influence of pharmacists' participation in the review of special prescriptions on the rationality of clinical application of antibacterial drugs [J]. Strait Pharm J (海峡药学), 2022, 34(4): 164-166.
[5] HU Y F, JI C C. The use of quinolones in a hospital and the occurrence of adverse reactions [J]. Chin Med Sci(中国医药科学), 2021, 11 (19): 106-108.
[6] KONG W H, FENG J J, ZHANG Q, et al. Progress in rational use of antimicrobials in China [J]. Chin J Ration Drug Use(中国合理用药探索), 2022, 19(8): 1-7.
[7] ZHU Y L, LI X. Current situation analysis and effect evaluation of antimicrobial management policies at home and abroad [J]. Chin J Pharmacovigil(中国药物警戒), 2021, 18(9):855-859.
[8] GOEBEL M C, TRAUTNER B W, GRIGORYAN L. The five ds of outpatient antibiotic stewardship for urinary tract infections [J]. Clin Microbiol Rev, 2021, 34(4): e0000320.
[9] DAVEY P, MARWICK C A, SCOTT C L, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients [J]. Cochrane Database Syst Rev, 2017, 2(2): Cd003543.
[10] PICKENS C I, WUNDERINK R G. Principles and practice of antibiotic stewardship in the ICU [J]. Chest, 2019, 156(1): 163-171.
[11] TIMSIT J F, BASSETTI M, CREMER O, et al. Rationalizing antimicrobial therapy in the ICU: a narrative review [J]. Intensive Care Med, 2019, 45(2): 172-189.
[12] MCGREGOR J C, FURUNO J P. Optimizing research methods used for the evaluation of antimicrobial stewardship programs [J]. Clin Infect Dis, 2014, 59(Suppl 3):S185-S192.
[13] PARENTE D M, MORTON J. Role of the pharmacist in antimicrobial stewardship [J]. Med Clin North Am, 2018, 102(5): 929-936.
[14] WANG H, WANG H, YU X, et al. Impact of antimicrobial stewardship managed by clinical pharmacists on antibiotic use and drug resistance in a Chinese hospital, 2010-2016: a retrospective observational study [J]. BMJ Open, 2019, 9(8): e026072. Doi: 10.1136/bmjopen-2018-026072.
[15] KITTEL-SCHNEIDER S, DAVIDOVA P, KALOK M, et al. A pilot study of multilevel analysis of BDNF in paternal and maternal perinatal depression [J]. Arch Womens Ment Health, 2022, 25(1): 237-249.
[16] BLEASDALE S C, BARNDEN M, BARNES S. The impact of antibiotic stewardship program resources on infection prevention programs [J]. Clin Infect Dis, 2019, 69(3): 552-553.
[17] WEI X, ZHANG Z, WALLEY J D, et al. Effect of a training and educational intervention for physicians and caregivers on antibiotic prescribing for upper respiratory tract infections in children at primary care facilities in rural China: a cluster-randomised controlled trial [J]. Lancet Glob Health, 2017, 5(12): e1258-e1267.
[18] POLINE J, POSTAIRE M, PARIZE P, et al. Stewardship program on carbapenem prescriptions in a tertiary hospital for adults and children in France: a cohort study [J]. Eur J Clin Microbiol Infect Dis, 2021, 40(5): 1039-1048.
[19] GARCÍA-RODRÍGUEZ J F, BARDÁN-GARCÍ A B, et al. Long-Term Carbapenems Antimicrobial Stewardship Program[J]. Antibiotics (Basel), 2020, 10(1):15-27. Doi: 10.3390/antibiotics10010015.
[20] MEI D, HU Y, YANG Y. Comprehensive management of clinical antibacterial drugs: from the experience of Peking Union Medical College to the national standard [J]. J Peking Union Med Coll(协和医学杂志), 2019, 10(5):531-538.
[21] DIDIODATO G, MCARTHUR L, BEYENE J, et al. Can an antimicrobial stewardship program reduce length of stay of immune-competent adult patients admitted to hospital with diagnosis of community-acquired pneumonia? Study protocol for pragmatic controlled non-randomized clinical study [J]. Trials, 2015, 16: 355. Doi: 10.1186/s13063-015-0871-2.
[22] LÓPEZ-CORTÉS L E, ROSSO-FERNÁNDEZ C, N'UÑEZ-N'UÑEZ M, et al. Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to Enterobacteriaceae (SIMPLIFY): a study protocol for a multicentre, open-label, phase Ⅲ randomised, controlled, non-inferiority clinical trial[J]. BMJ Open, 2017, 7(6): e015439. Doi: 10.1136/bmjopen-2016-015439.
[23] ABABNEH M A, AL DOMI M, RABABA'H A M. Antimicrobial use and mortality among intensive care unit patients with bloodstream infections: implications for stewardship programs[J]. Heliyon,2022, 8(8): e10076. Doi: 10.1016/j.heliyon.2022.e10076.
[24] YANG T G, SHI Y K, CHENG Y Z. Discussion on the definition and standard of average hospitalization days[J]. Chin Health Qual Manag(中国卫生质量管理), 2009,16(4):14-16.
[25] YANG H. Shane Thomas. Readmission: conceptual, measurement and policy implications [J]. Chin Health Qual Manag(中国卫生质量管理), 2009, 16(5):113-115.
[26] ZHANG X J, ZHA C M, CUI H, et al. Comparative analysis of new and old indicators of hospital infection rate [J]. Tianjing Nurs(天津护理), 2012, 20(5):283-284.
[27] BAUR D, GLADSTONE B P, BURKERT F, et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and clostridium difficile infection: a systematic review and meta-analysis [J]. Lancet Infect Dis, 2017, 17(9): 990-1001.
[28] STENEHJEM E, HERSH A L, BUCKEL W R, et al. Impact of implementing antibiotic stewardship programs in15 small hospitals:a cluster-randomized intervention [J]. Clin Infect Dis, 2018, 67(4): 525-532.
[29] BROTHERTON A L. Metrics of antimicrobial stewardship programs [J]. Med Clin North Am, 2018, 102(5): 965-976.
[30] BAGGS J, FRIDKIN S K, POLLACK L A, et al. Estimating national trends in inpatient antibiotic use among US hospitals from 2006 to 2012 [J]. JAMA Intern Med, 2016, 176(11): 1639-1648.
[31] Ch.P (2020) Vol Ⅰ(中国药典2020年版.一部)[S]. 2020:155-168.
[32] National Health and Family Planning Commission of the People's Republic of China. Guidelines for Clinical Application of Antibacterial Drugs(抗菌药物临床应用指南) [M]. Beijing: People's Health Publishing House, 2015:17-20.
[33] NOWAK M A, NELSON R E, BREIDENBACH J L, et al. Clinical and economic outcomes of a prospective antimicrobial stewardship program [J]. Am J Health Syst Pharm, 2012, 69(17): 1500-1508.
[34] KESHAVARZI F. Practical concerns about the metrics and methods of financial outcome measurement in antimicrobial stewardship programs: a narrative review[J]. Iranian J Med Sci, 2022, 47(5): 394-405.
[35] NATHWANI D, VARGHESE D, STEPHENS J, et al. Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review[J]. Antimicrob Resist Infect Control, 2019, 8:35. Doi: 10.1186/s13756-019-0471-0.
[36] MONTRAVERS P, TUBACH F, LESCOT T, et al. Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial [J]. Intensive Care Med, 2018, 44(3): 300-310.
[37] PUFFER S, TORGERSON D J, WATSON J. Cluster randomized controlled trials [J]. J Eval Clin Pract, 2005, 11(5): 479-483.
[38] COPAS A J, HOOPER R. Optimal design of cluster randomized trials allowing unequal allocation of clusters and unequal cluster size between arms [J]. Stat Med, 2021, 40(25): 5474-5486.
[39] LORENZ E, KÖPKE S, PFAFF H, et al. Cluster-randomized studies [J]. Deutsch Arzteblatt Int, 2018, 115(10): 163-168.
[40] DRON L, TALJAARD M, CHEUNG Y B, et al. The role and challenges of cluster randomised trials for global health [J]. Lancet Glob Health, 2021, 9(5): e701-e710.
[41] SAMSA G P, WINGER J G, COX C E, et al. Two questions about the design of cluster randomized trials: a tutorial [J]. J Pain Symptom Manage, 2021, 61(4): 858-863.
[42] NACE D A, HANLON J T, CRNICH C J, et al. A multifaceted antimicrobial stewardship program for the treatment of uncomplicated cystitis in nursing home residents [J]. JAMA Intern Med, 2020, 180(7): 944-951.
[43] LI H, GONG Y, HAN J, et al. Interrupted time-series analysis to evaluate the impact of a national antimicrobial stewardship campaign on antibiotic prescribing: a typical practice in China's primary care[J]. Clin Infect Dis, 2021, 73(11): e4463-e4471.
[44] BERNAL J L, CUMMINS S, GASPARRINI A. Interrupted time series regression for the evaluation of public health interventions: a tutorial [J]. Int J Epidemiol, 2017, 46(1): 348-355.
[45] PEÑALVA G, CRESPO-RIVAS J C, GUISADO-GIL A B, et al. Clinical and ecological impact of an educational program to optimize antibiotic treatments in nursing homes (PROA-SENIOR): a cluster, randomized, controlled trial and interrupted time-series analysis [J]. Clin Infect Dis, 2023, 76(5):824-832.
[46] MUKA T, GLISIC M, MILIC J, et al. A 24-step guide on how to design, conduct, and successfully publish a systematic review and meta-analysis in medical research [J]. Eur J Epidemiol, 2020, 35(1): 49-60.
[47] MOHER D, LIBERATI A, TETZLAFF J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement[J]. PLoS Med,2009, 6(7):e1000097. Doi: 10.1371/journal.pmed.1000097.
[48] HONDA H, OHMAGARI N, TOKUDA Y, et al. Antimicrobial stewardship in inpatient settings in the asia pacific region: a systematic review and Meta-analysis [J]. Clin Infect Dis, 2017, 64(suppl 2): S119-S126.
[49] LINDSAY P J, ROHAILLA S, TAGGART L R, et al. Antimicrobial stewardship and intensive care unit mortality: a systematic review [J]. Clin Infect Dis, 2019, 68(5): 748-756.

基金

中央高水平医院临床科研业务费资助(2022-PUMCH-B-059)
PDF(992 KB)

Accesses

Citation

Detail
段落导航
相关文章

/

〈 〉